CureVac N.V. (FRA:5CV)
4.382
-0.010 (-0.23%)
At close: Dec 5, 2025
CureVac Employees
As of December 31, 2024, CureVac had 983 total employees, including 825 full-time and 158 part-time employees. The number of employees decreased by 189 or -16.13% compared to the previous year.
Employees
983
Change (1Y)
-189
Growth (1Y)
-16.13%
Revenue / Employee
€78,253
Profits / Employee
€142,504
Market Cap
991.06M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Merck KGaA | 59,020 |
| Siemens Healthineers AG | 73,840 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fresenius Medical Care AG | 111,513 |
| Carl Zeiss Meditec AG | 5,730 |
| Fielmann Group AG | 24,363 |
CureVac News
- 3 days ago - BioNTech Secures Majority Of CureVac Shares As Exchange Offer Advances - Nasdaq
- 3 days ago - BioNTech Achieves Minimum Condition in CureVac Exchange Offer - GlobeNewsWire
- 8 days ago - CureVac N.V. (CVAC) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 10 days ago - BioNTech (BNTX) Moves Forward with CureVac Acquisition - GuruFocus
- 10 days ago - BioNTech (BNTX) Advances with Exchange Offer for CureVac Shares - GuruFocus
- 10 days ago - BioNTech’s exchange offer for German mRNA vaccine peer CureVac set to expire Dec. 3 - Seeking Alpha
- 11 days ago - CureVac Announces Voting Results of Extraordinary General Meeting - Accesswire
- 11 days ago - CureVac Reveals Key Voting Outcomes from Extraordinary Shareholder Meeting - Wallstreet:Online